Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP & CCO | November 07, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date November 07, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 23,337 |
Reported balance
After 2024-11-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-11-07 · Gift · Disposed 470 · Balance 23,337 F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust. |
| Common StockSEC Table I · non-derivative | Direct | 2,468 |
Reported balance
Holding disclosure · report date 2024-11-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,468 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2018 Filed Feb 26, 2018 19:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 274 | $109.34 | $29,959.16 |
DisclosureSEC source: 0001127602-18-008329 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,400 Read SEC document |
| February 24, 2018 Filed Feb 26, 2018 19:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 322 | $109.34 | $35,207.48 |
DisclosureSEC source: 0001127602-18-008329 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,674 Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 19:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 12,818 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-18-008329 · form4.xml · derivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,818 Underlying: Common Stock · 12,818 shares Expires 2023-02-23 F2 · derivative.exercise_date: Stock options vest as follows: 3,204 options vest one (1) year from the date of grant, 3,205 options vest two (2) years from the date of grant, 3,204 options vest three (3) years from the date of grant, and 3,205 options vest four (4) years from the date of grant. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 19:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-008329 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,996 F1 · security: Consists of 2,840 unvested restricted stock units that vest equally over four (4) years beginning one (1) year from the date of issuance. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 16:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $108.20 | $10,820.00 |
DisclosureSEC source: 0001127602-18-007667 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,156 Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 16:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $108.17 | $32,451.00 |
DisclosureSEC source: 0001127602-18-007667 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,256 Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 16:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 620 | $108.16 | $67,059.20 |
DisclosureSEC source: 0001127602-18-007667 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,556 Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 16:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,100 | $108.01 | $118,811.00 |
DisclosureSEC source: 0001127602-18-007667 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,176 Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 16:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $108.00 | $21,600.20 |
DisclosureSEC source: 0001127602-18-007667 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,276 Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 17:38 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 1,959 | $106.97 | $209,554.23 |
DisclosureSEC source: 0001127602-18-002598 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,476 Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 17:38 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 6,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002598 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,435 F1 · kind: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 27, 2015. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.07 | $10,007.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 20 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,924 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $100.01 | $30,003.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 19 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,024 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $100.00 | $30,000.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 18 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,324 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $100.00 | $19,999.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 17 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,624 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $99.98 | $29,994.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 16 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,824 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.98 | $9,997.50 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 15 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,124 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.96 | $9,996.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 14 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,224 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $99.95 | $29,983.50 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 13 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,324 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.94 | $9,994.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 12 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,624 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.93 | $9,993.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 11 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,724 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $99.92 | $29,976.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 10 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,824 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.91 | $9,991.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 9 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,124 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.90 | $9,990.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 8 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,224 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.89 | $9,989.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 7 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,324 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $99.88 | $39,952.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 6 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,424 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.86 | $9,986.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,824 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $99.85 | $9,985.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,924 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $99.78 | $19,956.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,024 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $99.78 | $19,955.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,224 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 10:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $99.77 | $49,885.00 |
DisclosureSEC source: 0001127602-17-026054 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,424 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $87.97 | $35,188.00 |
DisclosureSEC source: 0001127602-17-010566 · form4.xml · nonDerivative · entry 7 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,924 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $87.92 | $17,584.00 |
DisclosureSEC source: 0001127602-17-010566 · form4.xml · nonDerivative · entry 6 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,324 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.90 | $8,790.00 |
DisclosureSEC source: 0001127602-17-010566 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,524 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.89 | $8,789.00 |
DisclosureSEC source: 0001127602-17-010566 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,624 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.89 | $8,788.50 |
DisclosureSEC source: 0001127602-17-010566 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,724 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $87.88 | $35,152.00 |
DisclosureSEC source: 0001127602-17-010566 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,824 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 600 | $87.87 | $52,722.00 |
DisclosureSEC source: 0001127602-17-010566 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,224 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,015 | $0.00 Strike: $73.70 | $0.00 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · derivative · entry 34 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,045 Underlying: Common Stock · 3,015 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,315 | $0.00 Strike: $76.67 | $0.00 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · derivative · entry 33 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,316 Underlying: Common Stock · 4,315 shares Expires 2020-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,825 | $0.00 Strike: $59.41 | $0.00 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · derivative · entry 32 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,825 Underlying: Common Stock · 1,825 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,293 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · derivative · entry 31 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,293 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $87.87 | $26,359.50 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 30 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,824 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $87.86 | $26,358.00 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 29 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,124 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.86 | $8,785.50 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 28 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,424 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $87.85 | $35,140.00 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 27 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,524 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $87.85 | $26,353.50 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 26 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,924 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 66 | $87.84 | $5,797.44 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 25 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,224 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.84 | $8,783.50 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 24 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,290 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,100 | $87.83 | $96,613.00 |
DisclosureSEC source: 0001127602-17-010548 · form4.xml · nonDerivative · entry 23 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,390 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.